Nidufexor (Synonyms: Nidufexor) |
| Catalog No.GC34686 |
Nidufexor (LMB763) est un agoniste du récepteur farnésoÏde X (FXR) disponible par voie orale pour la recherche sur la stéatohépatite non alcoolique (NASH).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1773489-72-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Nidufexor is a farnesoid X receptor (FXR) agonist[1]. FXR[1]
[1]. Proposed INN: List 118. WHO Drug Information, Vol. 31, No. 4, 2017.
Review for Nidufexor
Average Rating: 5 (Based on Reviews and 13 reference(s) in Google Scholar.)
Review for Nidufexor
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *